SynthesisPloS one2015

CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.

Andreas Krieg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.